LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic ResponseFuming Li, Hongbin Ji, Zhaoyuan Fang et al.|Cancer Cell|2015Cited by 167
YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repressionYijun Gao, Hongbin Ji, Wenjing Zhang et al.|Nature Communications|2014Cited by 124
Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancerXinyuan Tong, Hongbin Ji, Ayushi S. Patel et al.|Cancer Cell|2024Cited by 115
YAP Promotes Malignant Progression of <i>Lkb1</i> -Deficient Lung Adenocarcinoma through Downstream Regulation of SurvivinWenjing Zhang, Hongbin Ji, Yijun Gao et al.|Cancer Research|2015Cited by 89
Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRASGuowei Yin, Yijun Gao|Signal Transduction and Targeted Therapy|2023Cited by 71